Effect of the delivery system on the biodistribution of Ge(IV) octabutoxy-phthalocyanines in tumour-bearing mice.

Abstract

The pharmacokinetic properties of the Ge(IV)-octabutoxy-phthalocyanines (GePc) with two axially ligated triethylsiloxy (GePcEt) or trihexyl-siloxy (GePcHex) chains were studied in BALB/C mice bearing a transplanted MS-2 fibrosarcoma. The GePcs were delivered to mice after incorporation into unilamellar liposomes of dipalmitoyl phosphatidylcholine (DPPC) or in an emulsion of Cremophor-EL. The Cremophor delivered GePcs were cleared from the blood circulation at a much slower rate than the liposome-delivered GePcs. At the same time, Cremophor induced a slower and reduced uptake of the GePcs in the liver and spleen while it greatly enhanced the uptake in the tumour as compared to liposomes. Maximum tumour uptake was observed at 24 h post-injection and was equivalent to 0.67 and 0.50 nmol/g, respectively, for the Cremophor delivered GePcHex and GePcEt. The corresponding values for the liposome-delivered drugs were approximately one fourth of that observed with Cremophor.

• Authors: M Soncin, L Polo, E Reddi, G Jori, M E Kenney, G Cheng, M A Rodgers
• Journal: Cancer letters (Cancer Lett) Vol. 89 Issue 1 Pg. 101-6 (Feb 10 1995) ISSN: 0304-3835 [Print] Ireland
• PMID: 7882292 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Drug Carriers
• Emulsions
• Indoles
• Liposomes
• Organometallic Compounds
• Photosensitizing Agents
• trihexylsiloxy-Ge(IV)-octabutoxyphthalocyanine
• bis(triethylsiloxy)-Ge(IV)-1,4,8,11,15,18,22,25-octabutoxyphthalocyanine
• 1,2-Dipalmitoylphosphatidylcholine
• cremophor EL
• Glycerol

Topics

• 1,2-Dipalmitoylphosphatidylcholine
• Animals
• Disease Models, Animal
• Drug Carriers
• Emulsions
• Female
• Glycerol (analogs & derivatives)
• Indoles (administration & dosage, pharmacokinetics)
• Liposomes
• Liver (metabolism)
• Mice
• Mice, Inbred BALB C
• Neoplasms, Experimental (metabolism)
• Organometallic Compounds (administration & dosage, pharmacokinetics)
• Photosensitizing Agents (administration & dosage, pharmacokinetics)
• Spleen (metabolism)
• Tissue Distribution